Bio-AMD Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Cash & Short Term Investments
3,877.80
2,936.30
1,921.90
717.10
437.40
Total Accounts Receivable
24.60
17.40
23.80
24.10
13.00
Other Current Assets
53.60
23.10
8.60
9.60
12.30
Total Current Assets
3,955.90
2,976.80
1,954.30
750.80
462.60
Net Property, Plant & Equipment
1.50
1.00
0.90
0.30
0.20
Other Assets
29.80
53.90
88.00
132.70
811.40
Total Assets
3,987.30
3,031.70
2,043.20
883.70
1,274.20
Accounts Payable
31.00
28.30
24.60
30.30
-
Other Current Liabilities
8.40
12.30
15.40
20.00
1,053.10
Total Current Liabilities
39.40
40.60
40.00
50.30
1,053.10
Total Liabilities
39.40
40.60
40.00
50.30
1,053.10
Common Equity (Total)
4,698.70
3,877.70
2,990.90
1,972.10
1,377.10
Total Shareholders' Equity
4,698.70
3,877.70
2,990.90
1,972.10
1,377.10
Total Equity
3,947.90
2,991.10
2,003.20
833.40
221.10
Liabilities & Shareholders' Equity
3,987.30
3,031.70
2,043.20
883.70
1,274.20
Accumulated Minority Interest
750.70
886.60
987.70
1,138.70
1,156.10

About Bio-AMD

View Profile
Address
Sci-Tech Daresbury
Daresbury Cheshire WA4 4FS
United Kingdom
Employees -
Website http://www.bioamd.com
Updated 09/14/2018
Bio-AMD, Inc. is a medical technology company, which focuses on Point of Care market. The company operates its business through the WOCU Limited and Bio-AMD Holdings segments. The WOCU Limited segment develops a technology designed to mitigate currency risk.